We are live on ! Find out more
NGNE icon

Neurogene
NGNE

33 hedge funds and large institutions have $183M invested in Neurogene in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

563% more capital invested

Capital invested by funds: $27.5M → $183M (+$155M)

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

22% more funds holding

Funds holding: 27 → 33 (+6)

Holders
33
Holders Change
+6
Holders Change %
+22.22%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
10
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$63.9M
2
RCM
RA Capital Management
Massachusetts
+$17.6M
3
VAM
Visium Asset Management
New York
+$13.4M
4
RG
Redmile Group
California
+$5.92M
5
Franklin Resources
Franklin Resources
California
+$5.76M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$3.69M
2
CAM
Cormorant Asset Management
Massachusetts
-$1.5M
3
DCM
Driehaus Capital Management
Illinois
-$1.14M
4
HCMT
Highland Capital Management (Texas)
Texas
-$1.09M
5
RA
Royce & Associates
New York
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$94.9M +$63.9M +277,499 +464%
RCM
2
RA Capital Management
Massachusetts
$21.6M +$17.6M +76,608 New
VAM
3
Visium Asset Management
New York
$19.7M +$13.4M +58,265 +497%
Franklin Resources
4
Franklin Resources
California
$15.6M +$5.76M +25,000 +82%
RG
5
Redmile Group
California
$7.24M +$5.92M +25,715 New
BA
6
BlackRock Advisors
Delaware
$4.32M +$2.21M +9,595 +166%
First Manhattan
7
First Manhattan
New York
$2.81M +$2.31M +10,006 New
BG
8
BlackRock Group
United Kingdom
$2.28M +$1.29M +5,590 +222%
CAM
9
Cormorant Asset Management
Massachusetts
$2.11M -$1.5M -6,495 -46%
BIT
10
BlackRock Institutional Trust
California
$2.1M +$1.72M +7,468 New
GPP
11
Great Point Partners
Connecticut
$1.41M +$1.15M +5,000 New
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$1.19M -$161K -697 -14%
SM
13
Sabby Management
Florida
$844K +$691K +3,000 New
PA
14
Perceptive Advisors
New York
$839K -$811K -3,520 -54%
Millennium Management
15
Millennium Management
New York
$788K +$645K +2,801 New
BlackRock
16
BlackRock
New York
$668K +$286K +1,240 +109%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$662K +$357K +1,549 +192%
Vanguard Group
18
Vanguard Group
Pennsylvania
$445K +$364K +1,582 New
Deutsche Bank
19
Deutsche Bank
Germany
$429K -$97.2K -422 -22%
Bank of Montreal
20
Bank of Montreal
Ontario, Canada
$414K +$294K +1,275 +654%
HCM
21
Highbridge Capital Management
New York
$399K +$327K +1,419 New
Tudor Investment Corp
22
Tudor Investment Corp
Connecticut
$352K +$288K +1,250 New
RA
23
Royce & Associates
New York
$262K -$1.09M -4,712 -84%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$244K +$200K +869 New
BIM
25
BlackRock Investment Management
Delaware
$218K +$179K +775 New
1
2

NGNE Hedge Fund Activity: Q3 2015 in Review

33 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q3 2015, worth a combined $183M — up 563% from $27.5M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new NGNE positions and 9 closed out — a net gain of 6 holders — while 10 added to existing stakes and 7 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $63.9M. The largest seller was Broadfin Capital, exiting entirely with an estimated $3.69M sold.

  • 33 institutional investors held Neurogene (NGNE) as of Q3 2015, up from 27 in Q2 2015.
  • Funds reported $183M of Neurogene stock for Q3 2015, up 563% quarter-over-quarter.
  • 15 funds opened new Neurogene positions in Q3 2015 and 9 closed out, a net change of +6 holders.
  • The largest Neurogene buyer in Q3 2015 was Baker Bros. Advisors, an estimated $63.9M added.
  • The largest Neurogene seller in Q3 2015 was Broadfin Capital, an estimated $3.69M sold.

Based on aggregated 13F filings for Q3 2015.